Although mild increase in BTZ-induced ROS contributes to BTZ resistance in MCL, simply blocking ROS by antioxidant NAC does not cause cell death but facilitates MCL survival upon BTZ treatment. The gene discussed is CASC3; the disease is mantle cell lymphoma.